Scynexis Inc
Scynexis Inc (SCYX) Implied Volatility Current
SCYX implied volatility is 103%. IV Rank is 49%, placing current premiums in the middle of their 52-week range.
Read more
Tracking SCYX implied volatility helps you identify when options premiums on Scynexis Inc are historically cheap or expensive, and where the best trades are hiding. Scynexis Inc implied volatility reflects the market's expectation of future price movement: when SCYX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Scynexis Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SCYX, tracking metrics like SCYX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SCYX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp.
The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SCYX implied volatility sits today versus where it has been. Our scanner ranks Scynexis Inc implied volatility against its historical range, surfaces extremes in SCYX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Scynexis Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 18, 2026
Trade options with IV on your side
Track SCYX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→